Lung Cancer Blood Tests and Other Screening Tools – Verywell Health

In this article by Lynne Eldridge, MD, published on Verywell Health in February 2025, new developments in blood-based screening for lung cancer are explored, with a focus on biomarker panels and enzyme detection technologies that may support earlier, less invasive diagnosis—particularly for non-smokers and former smokers who fall outside current CT screening guidelines.

The article references 2024 research led by Paul Dempsey, PhD, CSO and Co-founder of Hawkeye Bio, published in Communications Medicine, which details the development of a sensor panel that detects lung cancer–associated enzymes with 90% accuracy. Hawkeye Bio developed the LEAP (Lung Enzyme Activity Profile) test offered by Ease Healthcare.

This research, cited in multiple sections of the article, underscores the growing role of blood-based diagnostics in improving early detection and complements existing imaging tools like low-dose CT scans.

Read the full article:
Lung Cancer Blood Tests and Other Screening Tools – Verywell Health